News & Media

07 / 06 / 2021

Insud Pharma secures "Excellent" rating in the Profarma programme

It is a recognition of the brands of the group Chemo, Exeltis and mAbxience for their commitment to industrial development and investment in our country It is the second consecutive year that the group has received this rating from the Ministry of ...

More info
  • 20 / 01 / 2021

    Spanish group Insud Pharma signs agreement with AstraZeneca to manufacture COVID-19 vaccine candidate

    The plant in Spain's Castilla-La Mancha region will undertake vial filling and packaging for AZD1222 The company also provides drug substance manufacturing for AZD1222 through their site in Argentina Insud Pharma is at the forefront of Spanish ...

    More info
  • 17 / 08 / 2020

    mAbxience enters into an agreement with AstraZeneca to produce Covid-19 vaccine

    mAbxience, the biotec company of the Spanish Insud Pharma group, is deeply proud to announce that has entered into an agreement with AstraZeneca to produce a Covid-19 vaccine in Latin America. Our recently inaugurated plant in Garín (Argentina) will ...

    More info
  • 27 / 07 / 2020

    Insud Pharma secures "Excellent" rating in the Profarma programme

    The Spanish pharmaceutical group Insud Pharma and its brands Chemo, Exeltis and mAbxience have obtained the “EXCELLENT” rating in the Profarma Plan 2019, in recognition of their industrial activity and their commitment to development and innovation. ...

    More info
  • 16 / 04 / 2020

    Making available free paediatric medicine can accelerate elimination of congenital Chagas disease

    The donation of an essential antiparasitic medicine can potentially accelerate the elimination of Chagas disease infection in children. A pediatric presentation of benznidazole with accurate dosage and will soon be made available freely to address a long-standing ...

    More info
  • 20 / 05 / 2019

    Doctor Silvia Gold awarded Gold Medal by the Royal Academy of Medicine and Surgery of Murcia

    •This award is recognition of the hard work and dedication of Silvia Gold, President of the Mundo Sano Foundation, in changing the course of Chagas disease. •Mundo Sano is currently running the campaign Not a Single Baby with Chagas, to ensure ...

    More info
  • 26 / 04 / 2019

    Insud Pharma obtains again“very good” rating in the Profarma Programme

    Insud Pharma group have once again been rated “very good” in the 2018 edition of the Spanish government’s Profarma Programme, thanks to its industrial activity and commitment to R&D. The Programme is run by the Spanish Ministry of Economy, ...

    More info
  • 14 / 03 / 2019

    Mundo Sano launches "Not a Single Baby with Chagas" initiative to change the history of Chagas disease

    “Not a Single Baby with Chagas” is a reflection of the Foundation’s commitment to ensuring that by 2030 all babies born with Chagas disease can be treated and cured, and that all women of reproductive age have access to diagnosis and treatment. Every ...

    More info
  • 18 / 02 / 2019

    A 3D-printed human skin dressing, a migraine predictor and a smart insulin pen: the three startups selected for support by Insud Pharma

    BioDan, a 3D dressing derived from human skin which can be bioprinted and frozen, Brainguard, a wearable system that predicts migraines, and Insulclock, a system which monitors and controls the treatment of diabetes patients are the three startups selected ...

    More info
  • 30 / 01 / 2019

    Twelve startups present disruptive healthcare solutions at Insud Pharma’s Pitch Day

    The ChemoStart Programme is an initiative by Insud Pharma, spearheaded by Leandro Sigman, to support innovative healthcare startups In the second edition of the programme, 12 finalists have been shortlisted to present to a panel of experts at the Pitch ...

    More info
  • 17 / 12 / 2018

    FEIQUE recognises Química Sintética, a Spanish employment, investment and environmental leader

    FEIQUE, the Business Federation for the Spanish Chemical Industry, has recognised Chemo’s laboratories for the second year running Química Sintética outperformed competitors in three categories at the 2nd RSE Awards for the Chemical Sector   Madrid, ...

    More info
  • 24 / 09 / 2018

    Insud Pharma secures “very good” rating in the Profarma Programme

    Chemo and the entire Insud Pharma group have once again been rated “very good” in the 2017-2020 edition of the Spanish government’s Profarma Programme, thanks to our contribution to modernising the sector, our commitment to R&D and our clear ...

    More info
  • 16 / 07 / 2018

    The Autonomous University of Madrid and Insud Pharma 
join forces for biomedical innovation

    The Autonomous University of Madrid (UAM) and the multinational pharmaceutical company Insud Pharma are launching the UAM-Insud Pharma Programme of Innovation Challenges with a Strong Social Impact for biomedical innovation with an open innovation approach ...

    More info
  • 09 / 07 / 2018

    Chemo recognised at 2nd RSE Awards for the Chemical Sector

    Chemo’s Química Sintética plant garnered awards in the categories of job creation, environmental protection and investment The RSE Awards seek to reward the commitment of chemical sector companies that form part of the Responsible Care programme ...

    More info
  • 09 / 07 / 2018

    Chemo to attend CPhI Worldwide 2018

    Madrid, 27 July 2018.- The pharmaceutical sector event of the year is returning to Madrid from 9 to 11 October, and Chemo and the entire Insud Pharma Group are delighted to invite you to pop in and see us at stand 9F30, in Hall 9. Our participation ...

    More info
  • 12 / 03 / 2018

    Stopping the mother-to-child transmission of Chagas disease is the key to controlling the disease

    Barcelona, 8 March 2018. Every year, 8,000 are born across the world with the Trypanosoma cruzi infection, the parasite that causes Chagas disease. Of those babies, at least 20% will be diagnosed early and will receive treatment. According to experts ...

    More info
  • 19 / 12 / 2017

    CHEMO receives the Castilla-La Mancha business merit award for the most innovative company

    Its plant in Azuqueca de Henares, Liconsa, has been acclaimed for its commitment to innovation and investment in cutting-edge technologies The Director of Pharma Operations, José Prieto, was presented with the award by the President of Castilla-La ...

    More info
  • 24 / 11 / 2017

    INSUD PHARMA is the new name of Chemo Group

    Therefore, our three pharma brands, Chemo, Exeltis and mAbxience, are now grouped together under this name. This new identity is the result of the development and diversification of the company's pharma activity. Madrid, 24 November 2017–From ...

    More info
  • 10 / 11 / 2017

    WHO and Mundo Sano Foundation to facilitate access to paediatric treatment of Chagas disease

    8 November 2017 | Geneva −− The World Health Organization (WHO) and the Mundo Sano Foundation are working to make an essential antiparasitic medicine for treatment of Chagas disease widely accessible to children. Treatment with benznidazole in the ...

    More info
  • 02 / 10 / 2017

    The pharmaceutical Chemo Group opens a new plant in India

    Chemo India Formulations located in Hyderabad, have required an initial investment of around ₹100 crores (USD 16 million) Specialized in the development and manufacture of oral solid dosage forms, including tablets, caplets, hard gelatin capsules ...

    More info
  • 07 / 09 / 2017

    U.S. FDA Approves Chemo Group's Benznidazole to Treat Children with Chagas Disease

    On August 29th, the U.S. Food and Drug Administration (FDA) approved Chemo Research’s New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat Chagas disease. Benznidazole is an essential medicine for ...

    More info
  • 07 / 06 / 2017

    The pharmaceutical group Chemo opens two new plants in Spain which will produce injectable medicines

    The pharmaceutical multinational Chemo Group has just announced that it is opening two new plants that will produce injectable medicines. With these new facilities, the company now has a total of six plants in this country, employing more than 1,600 people ...

    More info
  • 31 / 03 / 2017

    Chemo Group committed to Corporate Social Responsibility

    As a business adhering to the Responsible Care programme, Chemo Group has recently been authorised to use the CSR-Corporate Social Responsibility branding after fulfilling all the necessary requirements. This stamp guarantees Chemo Group’s commitment ...

    More info
  • 21 / 12 / 2016

    Química Sintética: an example of solidarity

    The Spanish plant Química Sintética, located in Alcalá de Henares, has once again set an example with its solidarity. This year's project was the same as last year's and it consisted of sending the metal closures from raw material containers to a metal ...

    More info
  • 15 / 11 / 2016

    Grupo Chemo has been recognised by the CEOE-Cepyme Guadalajara (employers' confederation) as the largest employer

    The multinational pharmaceutical Grupo Chemo, together with its Liconsa plant, located in Azuqueca de Henares, has just received one of the Business Excellence Awards 2016 from the CEOE Guadalajara for the category of "Highest recruitment" in the area. The ...

    More info
  • 05 / 07 / 2016

    Química Sintética renews its ISO 14001 certification

    Our plant in Alcalá de Henares successfully passed a monitoring audit for the ISO 14001 Certificate for Environmental Management. The audit concluded without any “non-conformities” and the auditing team congratulated the staff on the good work being ...

    More info
  • 01 / 06 / 2016

    Mundo Sano, merit plaque in Castilla-La Mancha

    On 31 May, Mundo Sano foundation was recognized its work. The Governing Council of Castilla-La Mancha approved 20 distinctions awarded on the Day of the Region. Thirteen regional merit plaques were handed out in different fields. In our case, the foundation ...

    More info
  • 14 / 03 / 2016

    Chemo Group: among the most competitive companies in the pharma sector

    Chemo Group and mAbxience achieved the “Group A” and “Very Good” qualifications in the PROFARMA programme after an evaluation of its resources and industrial, economic and RD&I results. Profarma is a programme sponsored by the Ministry of ...

    More info
  • 26 / 02 / 2016

    Recognition for the quality of our Alcala de Henares plant's health and safety system

    The quality of the management of the health and safety system has been recognised once more and endorsed in the OSHAS-18001 audit performed by Bureau Veritas at our Alcalá de Henares site. Química Sintética passed with flying colours, obtaining a result ...

    More info
  • 07 / 01 / 2016

    Chemo renews the ISO 14001 environmental certificate of its Laboratorios Liconsa pharmaceutical plant in Azuqueca de Henares

    Once again, Liconsa has excelled in the audit of its ISO 14001 Environmental Management System, which was completed without any “non-conformities”. This reflects the good practices and correct implementation of the Environmental Management System ...

    More info
  • 20 / 12 / 2015

    CHEMO, excellent collaborator 2015

    The University of Alcalá de Henares (UAH) School of Pharmacy has named Chemo as this year’s “Excellent Collaborator 2015” for both its collaboration with the academic world and its recent contribution to student training activities, through both ...

    More info
  • 18 / 12 / 2015

    Química Sintética employees donate more than 580 afternoon snacks to Red Cross for Alcalá children at risk of social exclusion

    The employees of the Química Sintética plant have donated 585 afternoon snacks to Red Cross-Corredor del Henares for children at risk of social exclusion in Alcalá, the result of a humanitarian campaign thought up by one of its employees. The event ...

    More info
  • 16 / 12 / 2015

    CHEMO scoops up a prize at the Chemical Industry CSR I Awards

    The Federación Empresarial de la Industria Química Española, FEIQUE (Spanish Chemical Industry Federation), in collaboration with the Foro Química y Sociedad (Chemistry and Society Forum), judged the first edition of the CSR Awards. This prestigious ...

    More info
  • 11 / 09 / 2015

    Chemo, the lead sponsor of Club Deportivo Azuqueca

    Our company will be the image of the red and black club of Castile-La Mancha, and our name will appear on the players’ kits and in the San Miguel Stadium, where our boys will play many of next season’s matches. This the beginning of a long-term ...

    More info
  • 16 / 07 / 2015

    CHEMO, ready for next CPhI event in Madrid

    The CHEMO pharmaceutical company once again is preparing its presence at the industry’s annual event par excellence – the CPhI –Madrid from 13–15 October. After more than a decade of participating at the trade fair, the company will be able ...

    More info
  • 04 / 05 / 2015

    Entrepreneur of the Year

    Hugo Sigman, the founder of Chemo and CEO of Grupo INSUD, received the Ernst & Young Entrepreneur of the Year Award in Argentina. There was reason to celebrate on 23 April, as Hugo Sigman, the founder of Chemo and CEO of Grupo INSUD, received ...

    More info
  • 01 / 01 / 2015

    CHEMO awarded the “Tejiendo Sueños de Economía Social” prize by ASPRONA-León

    CHEMO pharmaceutical group’s twofold commitment to improving global health and contributing positively to the local communities where it conducts its business activities has been recognised with an award. The group’s León Farma facility has ...

    More info

Press Contact

Comunication department

Edificio Ebrosa
Manuel Pombo Angulo, 28 3ª planta
28050 Madrid, España

Tel: +34 91 771 15 00